HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedNCT00280566

Continuing ziprasidone or placebo with a mood stabilizer after mania improves

About this title

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)

Read the official source — NCT00280566
Medication studyAges 18+Multiple countriesBipolarity
The study in practice

Understand this study

Who was this study for?

This study was for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria applied.

Listed locations
Birmingham and 106 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2005
Recruitment status
Completed
Enrollment listed in the registry
584
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, France, Chile, ...
Age range
Over 18 Years
Official registry ID
NCT00280566
Official title
Show the full official title

A Phase 3, Randomized, 6-Month, Double-Blind Trial in Subjects With Bipolar I Disorder to Evaluate the Continued Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer (vs Placebo Plus a Mood Stabilizer) Following a Minimum of 2 Months of Response to Open-Label Treatment With Both Agents

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham, United States · Scottsdale, United States · Little Rock, United States

90 more locations
  • Costa Mesa, United States
  • Los Angeles, United States
  • National City, United States
  • Sacramento, United States
  • San Diego, United States
  • Temecula, United States
  • Altamonte Springs, United States
  • Fort Lauderdale, United States
  • Fort Myers, United States
  • Jacksonville, United States
  • Maitland, United States
  • Miami, United States
  • North Miami, United States
  • Orlando, United States
  • Tavares, United States
  • Decatur, United States
  • Smyrna, United States
  • Honolulu, United States
  • Des Plaines, United States
  • Libertyville, United States
  • Naperville, United States
  • Oak Brook, United States
  • Schaumburg, United States
  • Terre Haute, United States
  • Topeka, United States
  • Wichita, United States
  • Lexington, United States
  • Owensboro, United States
  • Baltimore, United States
  • Rockville, United States
  • Pittsfield, United States
  • Taunton, United States
  • Olive Branch, United States
  • Ridgeland, United States
  • Saint Charles, United States
  • Lincoln, United States
  • Omaha, United States
  • Las Vegas, United States
  • Nashua, United States
  • Paramus, United States
  • Teaneck, United States
  • Buffalo, United States
  • Olean, United States
  • Rochester, United States
  • Raleigh, United States
  • Cincinnati, United States
  • Columbus, United States
  • Toledo, United States
  • Bethany, United States
  • Oklahoma City, United States
  • Media, United States
  • Pittsburgh, United States
  • Memphis, United States
  • Arlington, United States
  • Austin, United States
  • Bellaire, United States
  • Dallas, United States
  • DeSoto, United States
  • Houston, United States
  • Santiago, Chile
  • Angoulême, France
  • Brest Naval, France
  • Douai, France
  • Mulhouse, France
  • Berlin, Germany
  • Cham, Germany
  • Essen, Germany
  • Guatemala City, Guatemala
  • New Territories, Hong Kong
  • Ellisbridge, India
  • Tirupati, India
  • Bangalore, India
  • Mysore, India
  • Chennai, India
  • Ludhiana, India
  • Pune, India
  • Catania, Italy
  • Florence, Italy
  • Parma, Italy
  • Pisa, Italy
  • Zapopan, Mexico
  • Mexico City, Mexico
  • Arkhangelskaya Obl, Primorsky Raion, Russia
  • Khot'kovo, Russia
  • Barcelona, Spain
  • Madrid, Spain
  • Taipei, Taiwan
  • Caracas, Venezuela
  • China
  • Russia
Checked Official study record (opens in a new tab)
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Did this study involve medication?

Yes. The study involved medication, including Placebo and Ziprasidone Oral Capsule.

Who was this study for?

This study was for people with bipolarity. Listed age limits: from 18 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies